Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Balabaud

Showing results (91-100 of 162) with videos related to

Pageof 17
Sort By:
Journal of Hepatology|May 10, 2008
The beta-catenin pathway is activated in focal nodular hyperplasia but not in cirrhotic FNH-like nodulesSandra Rebouissou, Gabrielle Couchy, Louis Libbrecht, et al.
Human Pathology|February 10, 2015
Well-differentiated hepatocellular neoplasm of uncertain malignant potentialCharles Balabaud, Paulette Bioulac-Sage, Linda Ferrell, et al.
Comparative Hepatology|July 16, 2009
Immunohistochemical study of the phenotypic change of the mesenchymal cells during portal tract maturation in normal and fibrous (ductal plate malformation) fetal liverJulien Villeneuve, Fanny Pelluard-Nehme, Chantal Combe, et al.
Research in Diagnostic and Interventional Imaging|July 30, 2024
Assessment of a multivariable model using MRI-radiomics, age and sex for the classification of hepatocellular adenoma subtypesGuillaume Declaux, Baudouin Denis de Senneville, Hervé Trillaud, et al.
Hepatology (Baltimore, Md.)|August 16, 2014
Telomerase reverse transcriptase promoter mutation is an early somatic genetic alteration in the transformation of premalignant nodules in hepatocellular carcinoma on cirrhosisJean Charles Nault, Julien Calderaro, Luca Di Tommaso, et al.
The Journal of Biological Chemistry|March 24, 2007
HNF1alpha inactivation promotes lipogenesis in human hepatocellular adenoma independently of SREBP-1 and carbohydrate-response element-binding protein (ChREBP) activationSandra Rebouissou, Sandrine Imbeaud, Charles Balabaud, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 22, 2017
Unexpected discovery of small HNF1α-inactivated hepatocellular adenoma in pathological specimens from patients resected for liver tumoursCharles Balabaud, Christophe Laurent, Brigitte Le Bail, et al.
Nature|November 21, 2008
Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumoursSandra Rebouissou, Mohamed Amessou, Gabrielle Couchy, et al.
European Radiology|December 8, 2018
New MRI features improve subtype classification of hepatocellular adenomaSylvain Bise, Nora Frulio, Arnaud Hocquelet, et al.
Journal of the American College of Surgeons|November 1, 2005
Prognostic factors and longterm survival after hepatic resection for hepatocellular carcinoma originating from noncirrhotic liverChristophe Laurent, Jean Frédéric Blanc, Steeve Nobili, et al.
Pageof 17

Showing results (91-100 of 162) with videos related to

Sort By:
Pageof 17
Journal of Hepatology|May 10, 2008
The beta-catenin pathway is activated in focal nodular hyperplasia but not in cirrhotic FNH-like nodulesSandra Rebouissou, Gabrielle Couchy, Louis Libbrecht, et al.
Human Pathology|February 10, 2015
Well-differentiated hepatocellular neoplasm of uncertain malignant potentialCharles Balabaud, Paulette Bioulac-Sage, Linda Ferrell, et al.
Comparative Hepatology|July 16, 2009
Immunohistochemical study of the phenotypic change of the mesenchymal cells during portal tract maturation in normal and fibrous (ductal plate malformation) fetal liverJulien Villeneuve, Fanny Pelluard-Nehme, Chantal Combe, et al.
Research in Diagnostic and Interventional Imaging|July 30, 2024
Assessment of a multivariable model using MRI-radiomics, age and sex for the classification of hepatocellular adenoma subtypesGuillaume Declaux, Baudouin Denis de Senneville, Hervé Trillaud, et al.
Hepatology (Baltimore, Md.)|August 16, 2014
Telomerase reverse transcriptase promoter mutation is an early somatic genetic alteration in the transformation of premalignant nodules in hepatocellular carcinoma on cirrhosisJean Charles Nault, Julien Calderaro, Luca Di Tommaso, et al.
The Journal of Biological Chemistry|March 24, 2007
HNF1alpha inactivation promotes lipogenesis in human hepatocellular adenoma independently of SREBP-1 and carbohydrate-response element-binding protein (ChREBP) activationSandra Rebouissou, Sandrine Imbeaud, Charles Balabaud, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 22, 2017
Unexpected discovery of small HNF1α-inactivated hepatocellular adenoma in pathological specimens from patients resected for liver tumoursCharles Balabaud, Christophe Laurent, Brigitte Le Bail, et al.
Nature|November 21, 2008
Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumoursSandra Rebouissou, Mohamed Amessou, Gabrielle Couchy, et al.
European Radiology|December 8, 2018
New MRI features improve subtype classification of hepatocellular adenomaSylvain Bise, Nora Frulio, Arnaud Hocquelet, et al.
Journal of the American College of Surgeons|November 1, 2005
Prognostic factors and longterm survival after hepatic resection for hepatocellular carcinoma originating from noncirrhotic liverChristophe Laurent, Jean Frédéric Blanc, Steeve Nobili, et al.
Pageof 17